47 results on '"de Bont, Eveline S.J.M."'
Search Results
2. Lysosomal Signaling Licenses Embryonic Stem Cell Differentiation via Inactivation of Tfe3
3. Targeting the reprogrammed metabolism in H3.3K27M pediatric high-grade gliomas
4. Identification of Two Protein-Signaling States Delineating Transcriptionally Heterogeneous Human Medulloblastoma
5. Neurofibromatosis type 1 associated low grade gliomas: A comparison with sporadic low grade gliomas
6. Risk-adapted approach for fever and neutropenia in paediatric cancer patients – A national multicentre study
7. Finding the right balance: An evaluation of the adequacy of energy and protein intake in childhood cancer patients
8. Changes in nutritional status in childhood cancer patients: A prospective cohort study
9. Clinical relevance of proteomic profiling in de novo pediatric acute myeloid leukemia: a Children’s Oncology Group study
10. Anti-angiogenic therapy in pediatric brain tumors: An effective strategy?
11. Simultaneous targeting of insulin-like growth factor-1 receptor and anaplastic lymphoma kinase in embryonal and alveolar rhabdomyosarcoma: A rational choice
12. Building the bridge between rhabdomyosarcoma in children, adolescents and young adults: The road ahead
13. Optimizing targeted cancer therapy: Towards clinical application of systems biology approaches
14. High IGSF4 expression in pediatric M5 acute myeloid leukemia with t(9;11)(p22;q23)
15. High-frequency type I/II mutational shifts between diagnosis and relapse are associated with outcome in pediatric AML: implications for personalized medicine
16. High VEGFC expression is associated with unique gene expression profiles and predicts adverse prognosis in pediatric and adult acute myeloid leukemia
17. VEGF-A promotes lymphoma tumour growth by activation of STAT proteins and inhibition of p27 KIP1 via paracrine mechanisms
18. AML at older age: age-related gene expression profiles reveal a paradoxical down-regulation of p16INK4A mRNA with prognostic significance
19. Risk assessment in fever and neutropenia in children with cancer: What did we learn?
20. Bone marrow-derived cells and tumor growth: Contribution of bone marrow-derived cells to tumor micro-environments with special focus on mesenchymal stem cells
21. Chemotherapy treatment in pediatric patients with acute myeloid leukemia receiving antimicrobial prophylaxis leads to a relative increase of colonization with potentially pathogenic bacteria in the gut
22. Dexamethasone in the maintenance phase of acute lymphoblastic leukaemia treatment: Is the risk of lethal infections too high?
23. Citrulline as a marker for chemotherapy induced mucosal barrier injury in pediatric patients1
24. Withholding Antibiotics From Patients With Febrile Neutropenia
25. Feasibility of Withholding Antibiotics in Selected Febrile Neutropenic Cancer Patients
26. Low Risk Episodes of Fever and Neutropenia in Pediatric Oncology: Is Outpatient Oral Antibiotic Therapy the New Gold Standard of Care?
27. Prognosis in childhood and adult acute lymphoblastic leukaemia: a question of maturation?
28. Influence of functional polymorphisms of the MDR1 gene on vincristine pharmacokinetics in childhood acute lymphoblastic leukemia
29. Lipopolysaccharide-binding protein: a possible diagnostic marker for Gram-negative bacteremia in neutropenic cancer patients
30. RNA-based FLT3-ITD allelic ratio is associated with outcome and ex vivo response to FLT3 inhibitors in pediatric AML
31. Fever and neutropenia in cancer patients: the diagnostic role of cytokines in risk assessment strategies
32. Weight and height in children newly diagnosed with cancer.
33. Impact of Additional Cytogenetic Abnormalities and Variant t(9;22) at Diagnosis on Prognosis of Childhood Chronic Myelogenous Leukemia : The Experience of the International Registry for CML in Children and Adolescents (I-CML-Ped Study)
34. The Experience of the International Registry for Chronic Myeloid Leukemia (CML) in Children and Adolescents (I-CML-Ped Study): Pronostic Consideration
35. Impairment of Longitudinal Growth By Tyrosine Kinase Inhibitor (TKI) Treatment - Data from a Large Pediatric Cohort with Chronic Myeloid Leukemia (CML)
36. Pharmacokinetic Results Of a Feasibility and Phase II Study (ITCC 021) On Bortezomib (BTZ) In Pediatric Relapsed ALL: Lack Of Significant Penetration Of BTZ In The Cerebrospinal Fluid
37. Kinomics Profiling Of Pediatric Acute Myeloid Leukemia Based On Prognosis
38. Identification of distinct protein Signatures Associated with genetic Abnormalities In Acute Lymphoblastic Leukemia
39. EphB2 activity plays a pivotal role in pediatric medulloblastoma cell adhesion and invasion.
40. Breast Cancer Resistance Protein (BCRP) in Acute Leukaemia.
41. High Functional P-blycoprotein Activity is More Often Present in T-cell Acute Lymphoblastic Leukaemic Cells in Adults than in Children.
42. A possible role for spontaneous interleukin-8 production by acute myeloid leukemic cells in angiogenesis related processes: Work in progress.
43. Overexpression of BRE in Pediatric MLL-Rearranged Acute Myeloid Leukemia Associated with t(9;11)(p22;q23).
44. Frequent Instability of Type I and II Aberrations Between Diagnosis and Relapse Observed in Pediatric Aml; Implications for Targeted Therapy and MRD Detection.
45. Identification of Gene Expression Signatures Accurately Predicting Cytogenetic Subtypes in Pediatric Acute Myeloid Leukemia.
46. High Expression of Multidrug Resistance-Associated Proteins Predicts Prognosis in Acute Lymphoblastic Leukemia in Children and Adults.
47. The Diagnostic Value of Interleukin-8 for the Detection of Bacteremia in Pediatric Hematopoietic Stem Cell Recipients With Febrile Neutropenia.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.